The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.
In this commentary for Barron's, KFF's Cynthia Cox and Jennifer Kates explore what will happen with costs to COVID-19 vaccines for people with and without insurance once the relevant public health emergency ends on May 11.
This analysis examines monkeypox (MPX) cases and vaccinations by race/ethnicity based on national data obtained from the Centers for Disease Control and Prevention (CDC). We find that while the current MPX outbreak in U.S. appears to be slowing down, disparities persist among Black and Hispanic people.
This volume examines recent social media and AI policy changes; conflicting studies on COVID-19 vaccines and cancer; ACOG guidance on contraceptive misinformation; an alternative to the CDC’s MMWR; the Texas AG’s Tylenol lawsuit; and findings from a recent KFF Tracking Poll on trust in health care apps and websites that use AI.
This volume examines how AI-generated videos contributed to false narratives about SNAP recipients; findings from KFF’s Health Tracking Poll on beliefs about undocumented immigrants’ ACA eligibility; how a new film amplifies false vaccine claims; Louisiana’s delayed whooping cough response; medical education efforts to address shame; and teens’ distrust of news media.
This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to interpret lab results.
This volume examines how prompting techniques can reduce incorrect medical information from AI chatbots; false claims linking vaccines to sudden infant death syndrome; the promotion of an industrial solvent as an allegedly suppressed cancer cure; misunderstandings about the risks of overdose from fentanyl exposure; and ongoing myths about sunscreen safety.
This volume explores confusion around COVID-19 booster eligibility as federal recommendations shift and conflicts with guidance from physician organizations; Florida’s decision to end school vaccine mandates; and research demonstrating that artificial intelligence chatbots can provide generally sound advice, but struggle to make personalized recommendations.
With recent federal actions to curtail vaccine access, many states have announced actions intended to maintain broader access. This issue brief provides a snapshot of this rapidly changing landscape, tracking which states have instituted changes in response to or in anticipation of administration policy changes.
© 2026 KFF